APA

Fennell D. A., McDowell C., Busacca S., Webb G., Moulton B., Cakana A., O'Byrne K. J., Meerbeeck J. V., Donnellan P., McCaffrey J. & Baas P. (20130117). Phase II clinical trial of first or second-line treatment with bortezomib in patients with malignant pleural mesothelioma. : Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Chicago

Fennell Dean A, McDowell Cliona, Busacca Sara, Webb Glen, Moulton Brian, Cakana Andrew, O'Byrne Kenneth J, Meerbeeck Jan V, Donnellan Paul, McCaffrey John and Baas Paul. 20130117. Phase II clinical trial of first or second-line treatment with bortezomib in patients with malignant pleural mesothelioma. : Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Harvard

Fennell D. A., McDowell C., Busacca S., Webb G., Moulton B., Cakana A., O'Byrne K. J., Meerbeeck J. V., Donnellan P., McCaffrey J. and Baas P. (20130117). Phase II clinical trial of first or second-line treatment with bortezomib in patients with malignant pleural mesothelioma. : Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

MLA

Fennell Dean A, McDowell Cliona, Busacca Sara, Webb Glen, Moulton Brian, Cakana Andrew, O'Byrne Kenneth J, Meerbeeck Jan V, Donnellan Paul, McCaffrey John and Baas Paul. Phase II clinical trial of first or second-line treatment with bortezomib in patients with malignant pleural mesothelioma. : Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 20130117.